Rinne, U K <br/><br/>
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.  [electronic resource] 

 -  Journal of neurology  Dec 1975 
 - 1-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0340-5354 
<br/><br/><label>Standard No.: </label>10.1007/BF00312459  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aromatic Amino Acid Decarboxylase Inhibitors<br/>Benserazide--administration & dosage<br/>Blood Pressure--drug effects<br/>Clinical Trials as Topic<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hydrazines--administration & dosage<br/>Levodopa--administration & dosage<br/>Male<br/>Middle Aged<br/>Movement Disorders--chemically induced<br/>Nausea--chemically induced<br/>Parkinson Disease--drug therapy<br/>Vomiting--chemically induced